Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

589 ARTÍCULOS , VIENDO DEL 406 AL 420

Impact of Major Depressive Disorder on Comorbidities: A Systematic Literature Review

Arnaud AM, Brister TS, Duckworth K, Foxworth P, Fulwider T, Suthoff ED, Werneburg B, Aleksanderek I, Reinhart ML.

J Clin Psychiatry. 2022 Oct 19;83(6):21r14328. doi: 10.4088/JCP.21r14328.

Cognitive improvement effects of Tian Wang Bu Xin Dan (Cheonwangbosimdan) in patients with mild cognitive impairment: protocol for a randomized placebo-controlled pilot clinical trial

Kim JH, Cho MR, Yoo J, Park GC, Lee JS.

Ann Palliat Med. 2022 Oct;11(10):3320-3329. doi: 10.21037/apm-22-701. Epub 2022 Oct 11.

Adjudicating Mild Cognitive Impairment Due to Alzheimer's Disease as a Novel Endpoint Event in the TOMMORROW Prevention Clinical Trial

Schneider LS, Bennett DA, Farlow MR, Peskind ER, Raskind MA, Sano M, Stern Y, Haneline S, Welsh-Bohmer KA, O'Neil J, Walter R, Maresca S, Culp M, Alexander R, Saunders AM, Burns DK, Chiang C.

J Prev Alzheimers Dis. 2022;9(4):625-634. doi: 10.14283/jpad.2022.72.

Genistein effect on cognition in prodromal Alzheimer's disease patients. The GENIAL clinical trial

Viña J, Escudero J, Baquero M, Cebrián M, Carbonell-Asíns JA, Muñoz JE, Satorres E, Meléndez JC, Ferrer-Rebolleda J, Cózar-Santiago MDP, Santabárbara-Gómez JM, Jové M, Pamplona R, Tarazona-Santabalbina FJ, Borrás C.

Alzheimers Res Ther. 2022 Nov 4;14(1):164. doi: 10.1186/s13195-022-01097-2.

Effects of Kami Guibi-tang in patients with mild cognitive impairment: study protocol for a phase III, randomized, double-blind, and placebo-controlled trial

Shin HY, Yim TB, Heo HM, Jahng GH, Kwon S, Cho SY, Park SU, Jung WS, Moon SK, Ko CN, Park JM.

BMC Complement Med Ther. 2022 Dec 2;22(1):318. doi: 10.1186/s12906-022-03805-9.

Extra-Virgin Olive Oil Enhances the Blood-Brain Barrier Function in Mild Cognitive Impairment: A Randomized Controlled Trial

Kaddoumi A, Denney TS Jr, Deshpande G, Robinson JL, Beyers RJ, Redden DT, Praticò D, Kyriakides TC, Lu B, Kirby AN, Beck DT, Merner ND.

Nutrients. 2022 Dec 1;14(23):5102. doi: 10.3390/nu14235102.

An Insight into the Role of Artificial Intelligence in the Early Diagnosis of Alzheimer's Disease

Verma RK, Pandey M, Chawla P, Choudhury H, Mayuren J, Bhattamisra SK, Gorain B, Raja MAG, Amjad MW, Obaidur Rahman S.

CNS Neurol Disord Drug Targets. 2022;21(10):901-912. doi: 10.2174/1871527320666210512014505.

Circulatory GSK-3β: Blood-Based Biomarker and Therapeutic Target for Alzheimer's Disease

Kumari S, Singh A, Singh AK, Yadav Y, Bajpai S, Kumar P, Upadhyay AD, Shekhar S, Dwivedi S, Dey AB, Dey S.

J Alzheimers Dis. 2022;85(1):249-260. doi: 10.3233/JAD-215347.

A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment

Levey AI, Qiu D, Zhao L, Hu WT, Duong DM, Higginbotham L, Dammer EB, Seyfried NT, Wingo TS, Hales CM, Gámez Tansey M, Goldstein DS, Abrol A, Calhoun VD, Goldstein FC, Hajjar I, Fagan AM, Galasko D, Edland SD, Hanfelt J, Lah JJ, Weinshenker D.

Brain. 2022 Jun 30;145(6):1924-1938. doi: 10.1093/brain/awab452.

Potential Roles of α-amylase in Alzheimer's Disease: Biomarker and Drug Target

Chen WN, Tang KS, Yeong KY.

Curr Neuropharmacol. 2022;20(8):1554-1563. doi: 10.2174/1570159X20666211223124715.

Probiotic supplementation demonstrates therapeutic potential in treating gut dysbiosis and improving neurocognitive function in age-related dementia

Meng HYH, Mak CCH, Mak WY, Zuo T, Ko H, Chan FKL.

Eur J Nutr. 2022 Jun;61(4):1701-1734. doi: 10.1007/s00394-021-02760-4. Epub 2022 Jan 10.

Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer's disease: a randomized trial

Kellar D, Register T, Lockhart SN, Aisen P, Raman R, Rissman RA, Brewer J, Craft S.

Sci Rep. 2022 Jan 25;12(1):1346. doi: 10.1038/s41598-022-05165-3.

Challenges and hopes for Alzheimer's disease

Tatulian SA.

Drug Discov Today. 2022 Apr;27(4):1027-1043. doi: 10.1016/j.drudis.2022.01.016. Epub 2022 Feb 1.

Considerations regarding a diagnosis of Alzheimer's disease before dementia: a systematic review

van der Schaar J, Visser LNC, Bouwman FH, Ket JCF, Scheltens P, Bredenoord AL, van der Flier WM.

Alzheimers Res Ther. 2022 Feb 10;14(1):31. doi: 10.1186/s13195-022-00971-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias